These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37454734)

  • 1. Interpretable machine learning to predict adverse perinatal outcomes: examining marginal predictive value of risk factors during pregnancy.
    Lee SJ; Garcia GP; Stanhope KK; Platner MH; Boulet SL
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101096. PubMed ID: 37454734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental protein levels in maternal serum are associated with adverse pregnancy outcomes in nulliparous patients.
    Parry S; Carper BA; Grobman WA; Wapner RJ; Chung JH; Haas DM; Mercer B; Silver RM; Simhan HN; Saade GR; Reddy UM; Parker CB;
    Am J Obstet Gynecol; 2022 Sep; 227(3):497.e1-497.e13. PubMed ID: 35487327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Akolekar R; Ciobanu A; Zingler E; Syngelaki A; Nicolaides KH
    Am J Obstet Gynecol; 2019 Jul; 221(1):65.e1-65.e18. PubMed ID: 30878322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
    Akolekar R; Panaitescu AM; Ciobanu A; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):484-491. PubMed ID: 31271475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of marginal cord insertion on perinatal outcomes: a systematic review and meta-analysis.
    Siargkas A; Tsakiridis I; Pachi C; Mamopoulos A; Athanasiadis A; Dagklis T
    Am J Obstet Gynecol MFM; 2023 Apr; 5(4):100876. PubMed ID: 36708965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Interpretable Longitudinal Preeclampsia Risk Prediction Using Machine Learning.
    Eberhard BW; Cohen RY; Rigoni J; Bates DW; Gray KJ; Kovacheva VP
    medRxiv; 2023 Aug; ():. PubMed ID: 37645797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebroplacental ratio as predictor of adverse perinatal outcome in the third trimester.
    Bonnevier A; Maršál K; Brodszki J; Thuring A; Källén K
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):497-503. PubMed ID: 33078387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of small-for-gestational-age neonates at 35-37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks.
    Ciobanu A; Anthoulakis C; Syngelaki A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 May; 53(5):630-637. PubMed ID: 30912210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of velamentous cord insertion on perinatal outcomes: a systematic review and meta-analysis.
    Siargkas A; Tsakiridis I; Pachi C; Mamopoulos A; Athanasiadis A; Dagklis T
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100812. PubMed ID: 36379439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation.
    Ashoor G; Syngelaki A; Papastefanou I; Nicolaides KH; Akolekar R
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):61-68. PubMed ID: 34643306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):308-15. PubMed ID: 25970847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second trimester cerebroplacental ratio versus umbilicocerebral ratio for the prediction of adverse perinatal outcomes.
    Winchester ML; McCarther N; Cancino D; Fitzgerald S; Parrish M
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7929-7935. PubMed ID: 34151683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal placental assessment in the prediction of adverse pregnancy outcome after reduced fetal movement.
    Higgins LE; Myers JE; Sibley CP; Johnstone ED; Heazell AEP
    PLoS One; 2018; 13(11):e0206533. PubMed ID: 30395584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude of change in fetal cerebroplacental ratio in third trimester and risk of adverse pregnancy outcome.
    Flatley C; Greer RM; Kumar S
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):514-519. PubMed ID: 27873370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.